Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Clinical Trial to Study the Effectiveness and Safety of a Digitally Based Multidomain Intervention for Mild Cognitive Impairment

NCT05059353 is registered in ClinicalTrials.gov with Neuroglee Therapeutics as lead sponsor.

NCT NCT05059353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05059353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Clinical Trial to Study the Effectiveness and Safety of a Digitally Based Multidomain Intervention for Mild Cognitive Impairment
Lead sponsor
Neuroglee Therapeutics
Phase
Not applicable
Overall status
Completed
Start date
November 1, 2021
Completion date
August 31, 2022
Enrollment
55 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mild cognitive impairment